Evong Y, Luo J, Ye L, Fahey J, et al. Increased respiratory syncytial virus-associated hospitalizations and ambulatory visits in very preterm infants in the first year of life following discontinuation of access to palivizumab. Am J Perinatol 2025 Jan 9. doi: 10.1055/a-2512-9453.
PMID: 39788540